Results 161 to 170 of about 4,777,622 (429)
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer
Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted therapy have made only limited progress in recent years in improving the generally disappointing outcome.
D. Vrána+8 more
semanticscholar +1 more source
Parkinson's disease (PD) progression is aggravated by disrupted inter‐organelle contacts, which are influenced by mechanical forces. NanoMassage, 200 nm PEGylated black phosphorus nanosheets, deliver targeted mechanical stimulation to neural cells.
Tianqi Li+12 more
wiley +1 more source
Nurse-led Follow-up and Palliative Care of Esophageal Cancer Patients [PDF]
Approximately 400,000 patients are annually diagnosed world-wide with esophageal cancer, which makes this malignancy the eight most common cancer (1). The incidence of esophageal cancer has risen remarkably over the past two decades in the Western world,
Verschuur, E.M.L. (Els)
core +5 more sources
Background PD‐L1 expression in tumors and immune cells is a biomarker for the efficacy of anti‐PD‐1 antibody (APA) therapy across diverse cancers. Based on the results from the KEYNOTE‐048 trial, pembrolizumab monotherapy is indicated for platinum ...
Akihiro Ohara+6 more
doaj +1 more source
BackgroundNeoadjuvant therapy is preferentially recommended for resectable locally advanced esophageal malignancies, with patients who achieve pathological complete response (PCR) anticipated to have longer survival rates.
Hai Zhang+12 more
doaj +1 more source
A Methodology for Customizing Clinical Tests for Esophageal Cancer based on Patient Preferences [PDF]
Tests for Esophageal cancer can be expensive, uncomfortable and can have side effects. For many patients, we can predict non-existence of disease with 100% certainty, just using demographics, lifestyle, and medical history information. Our objective is to devise a general methodology for customizing tests using user preferences so that expensive or ...
arxiv
at a glance..: one-minute abstracts of the literature on gastric and esophageal cancer... [PDF]
openalex +1 more source
Silica and esophageal cancer in Golestan province northeast of Iran [PDF]
Objectives: Association of silica with diseases like cancers has been determined previously. This study was designed to determine the quantity of silis in flour produced in Golestan province and its relation to the esophageal cancer. Methodology: We took
Besharat, S., Jabbari, A., Semnani, S.
core
A good start of immunotherapy in esophageal cancer
Considering the benefits of immunotherapy in advanced melanoma, non–small cell lung cancer, renal cell carcinoma, bladder cancers, and refractory Hodgkin lymphoma, we begin to consider whether immunotherapy is effective for esophageal cancer, which is ...
Qian Zhao, Jinming Yu, Xue Meng
semanticscholar +1 more source
PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
Pancreatic ductal adenocarcinoma features abundant stromal components that hinder therapy efficacy. Single‐cell RNA sequencing analysis combined with experiments identified PPY, a gastrointestinal hormone, as a novel inducer of immunosuppressive iCAFs. Mechanistic studies revealed that PPY activates the non‐canonical NF‐κB pathway via EGFR.
Mengdie Cao+14 more
wiley +1 more source